Williams Eugene 4

What Happened
Eugene Williams, a director of ProMIS Neurosciences, purchased 2,000 shares of PMN common stock in an open-market transaction on March 5, 2026. The shares were acquired at $24.40 each for a total reported value of $48,800. This was a purchase (transaction code P), which investors often view as a direct insider acquisition rather than a sale.

Key Details

• Transaction date and price: March 5, 2026 — 2,000 shares at $24.40 per share.
• Total value: $48,800.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Notable footnotes: None reported in the provided summary (no 10b5-1 plan, tax withholding, or gift notation indicated).
• Filing timeliness: Report filed March 6, 2026 (one day after the transaction); appears timely under Form 4 reporting rules.

Context
This was an open-market purchase by a company director. Insider purchases can be interpreted by some investors as a sign of confidence, but they are only one data point and do not guarantee future stock performance. Retail investors may want to track additional insider transactions and company disclosures for broader context.